Epstein-Barr virus’s new approach for causing diseases
90% of the adult population is infected with EBV, which often causes no symptoms or sickness.
Editor's Desk
Recurring COVID-19 vaccines produce antibodies that fight off other viruses and their variations.
Despite being influenced by prior vaccinations, the new vaccine produces widely neutralizing antibodies in response.
Natural vanillin extracted from plants rapidly using a Bioengineered enzyme
Natural vanilla extract is becoming harder to get and costs more money because of climate limitations on growing the plant and the low yields that each plant produces.
A study revealed that metastatic cancers in mice can be cured by a plant virus treatment
When the medication was given to mice whose tumors had been surgically removed, similar results were also shown.
CRISPR gene editing trials for vision show rapid improvement
The CRISPR technology-based experimental gene editing medication EDIT-101, created by Editas Medicine, was tested for safety and efficacy in the BRILLIANCE study
An experimental monoclonal antibody drug called mAb43 can protect pancreas cells from immune system attack
The drug is special, say the researchers, since it specifically targets the beta cells in the pancreas that produce insulin and is made to protect those cells against the immune system attacks.
Advanced heart regenerative therapy using stem cell-derived heart muscle cells
Human induced pluripotent stem cells (HiPSCs) represent one exciting approach that is gradually gaining popularity in the field of regenerative cardiac treatment.
Single Cell Atlas; a pioneer for biomedical research
The goal is to produce an essential instrument that will assist researchers globally in understanding more about human health and illness.
Prostate cancer can be detected by a urine test
The test, which examines 18 genes, was created especially to identify malignancies that require rapid treatment as opposed to those that grow slowly.
A new way to boost the immune cells to fight against cancer cells
To increase the efficacy of treatment, scientists from Virginia Tech’s College of Engineering have created a novel cancer immunotherapy that targets cancer-killing cytokines where they are found in tumours.
